| BCBS Highmark NY and West NY | Amivantamab-vmjw (Rybrevant) and Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | 2026-03-02 |
| BCBS Highmark NY and West NY | Granulocyte Colony-Stimulating Factors | 2026-03-02 |
| BCBS Highmark NY and West NY | Chimeric Antigen Receptor T-Cell and T-Cell Receptor Therapies | 2026-03-02 |
| BCBS Highmark Delaware | Partial Hospitalization Programs | 2026-03-02 |
| BCBS Highmark Delaware | Intensive Outpatient Programs | 2026-03-02 |
| BCBS Highmark Delaware | Non-Surgical Management of Nasal Airway Obstruction | 2026-03-02 |
| BCBS Highmark Delaware | GI Effects Comprehensive Stool Profile | 2026-03-02 |
| BCBS Highmark Delaware | ProAct: Adjustable Continence Therapy for Men | 2026-03-02 |
| BCBS Highmark Delaware | Mosunetuzumab-axgb (Lunsumio) and mosunetuzumab-axgb (Lunsumio Velo) | 2026-03-02 |
| BCBS Highmark West Virginia | Intensive Outpatient Programs | 2026-03-02 |